| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1041 |
| Trial ID | ChiCTR-OIC-17012374 |
| Disease | Hematologic Cancer |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | allogeneic hematopoietic stem cell transplantation |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical study on the safety and efficacy of allogeneic hematopoietic stem cell transplantation combined with CD19 CAR-T in the treatment of B-cell hematologic malignancies |
| Year | 2017 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||